Kardigan (KARD) vs Kailera Therapeutics (KLRA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Kardigan is the larger company by market cap ($1.33 billion vs $1.30 billion), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | KARD | KLRA |
|---|---|---|
| Share price | $14.20 | $10.00 |
| Market cap | $1.33B | $1.30B |
| 1-day change | +2.68% | -5.03% |
| EPS (TTM) | $-10.65 | $-4.51 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $27.00 | $28.23 |
| 52-week low | $12.23 | $9.76 |
| Distance from 52-week high | -47.41% | -64.58% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +197.54% | +324.00% |
| Average volume | 483.42K | 861.01K |
| Shares outstanding | 93.50M | 129.64M |
| Employees | 241 | 145 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Kardigan
KARD stock →Kardigan, Inc. operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 241 employees
About Kailera Therapeutics
KLRA stock →Kailera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company developing therapies for obesity and related conditions.
Health Care · Biotechnology: Pharmaceutical Preparations · 145 employees
KARD vs KLRA FAQ
Which is bigger, Kardigan or Kailera Therapeutics?
Kardigan (KARD) is larger, with a market capitalization of $1.33B compared with $1.30B for Kailera Therapeutics (KLRA).
Are Kardigan and Kailera Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.